Table 4. Linear regression model of visual acuity differences of affected eye from nadir to follow-up.
HC-BCVA difference | |||
---|---|---|---|
Predictors | regression coefficient b | 95%-Confidence interval | p value |
(Intercept) | 0.51 | 0.09–0.92 | 0.018 |
Gender [Male] | -0.10 | -0.36–0.16 | 0.454 |
Age at ON Onset | -0.00 | -0.01–0.01 | 0.774 |
Time to treatment | -0.01 | -0.01–0.00 | 0.205 |
OPT | 0.11 | -0.12–0.35 | 0.332 |
Observations n = 51. R2/R2 adjusted 0.073/-0.010. HC-BCVA: high-contrast best corrected visual acuity, documented as logMAR equivalent. ON: Optic neuritis. OPT: Oral prednisone tapering.